packageElapegademase

elapegademase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Elapegademase is an enzyme replacement therapy used to treat adenosine deaminase deficiency causing severe combined immunodeficiency. It is an approved medicine, used as an injectable immunostimulant therapy for this rare immune disorder.

Summary written by glm-5.3-flash from Wikidata Q65087024 and the WHO ATC classification; not checked by a person.

name:elapegademase
ATC codes:L03AX21
DrugBank:DB14712
Wikidata:Q65087024
molar mass:248.28 g/mol (Drugs.Common 25.09, not verified)
logP:-2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown